IBDEI0T7 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13140,1,4,0)
 ;;=4^H16.292
 ;;^UTILITY(U,$J,358.3,13140,2)
 ;;=^5133471
 ;;^UTILITY(U,$J,358.3,13141,0)
 ;;=H16.291^^51^629^54
 ;;^UTILITY(U,$J,358.3,13141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13141,1,3,0)
 ;;=3^Keratoconjunctivitis,Other,OD
 ;;^UTILITY(U,$J,358.3,13141,1,4,0)
 ;;=4^H16.291
 ;;^UTILITY(U,$J,358.3,13141,2)
 ;;=^5004944
 ;;^UTILITY(U,$J,358.3,13142,0)
 ;;=H16.293^^51^629^56
 ;;^UTILITY(U,$J,358.3,13142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13142,1,3,0)
 ;;=3^Keratoconjunctivitis,Other,OU
 ;;^UTILITY(U,$J,358.3,13142,1,4,0)
 ;;=4^H16.293
 ;;^UTILITY(U,$J,358.3,13142,2)
 ;;=^5004945
 ;;^UTILITY(U,$J,358.3,13143,0)
 ;;=H18.602^^51^629^58
 ;;^UTILITY(U,$J,358.3,13143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13143,1,3,0)
 ;;=3^Keratoconus,Unspec,OS
 ;;^UTILITY(U,$J,358.3,13143,1,4,0)
 ;;=4^H18.602
 ;;^UTILITY(U,$J,358.3,13143,2)
 ;;=^5005090
 ;;^UTILITY(U,$J,358.3,13144,0)
 ;;=H18.601^^51^629^57
 ;;^UTILITY(U,$J,358.3,13144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13144,1,3,0)
 ;;=3^Keratoconus,Unspec,OD
 ;;^UTILITY(U,$J,358.3,13144,1,4,0)
 ;;=4^H18.601
 ;;^UTILITY(U,$J,358.3,13144,2)
 ;;=^5005089
 ;;^UTILITY(U,$J,358.3,13145,0)
 ;;=H21.89^^51^629^45
 ;;^UTILITY(U,$J,358.3,13145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13145,1,3,0)
 ;;=3^Iris & Ciliary Body Disorders,Other Specified
 ;;^UTILITY(U,$J,358.3,13145,1,4,0)
 ;;=4^H21.89
 ;;^UTILITY(U,$J,358.3,13145,2)
 ;;=^5005265
 ;;^UTILITY(U,$J,358.3,13146,0)
 ;;=H21.1X2^^51^629^46
 ;;^UTILITY(U,$J,358.3,13146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13146,1,3,0)
 ;;=3^Iris & Ciliary Body Vasular Disorders,Other,OS
 ;;^UTILITY(U,$J,358.3,13146,1,4,0)
 ;;=4^H21.1X2
 ;;^UTILITY(U,$J,358.3,13146,2)
 ;;=^5005176
 ;;^UTILITY(U,$J,358.3,13147,0)
 ;;=H21.1X1^^51^629^47
 ;;^UTILITY(U,$J,358.3,13147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13147,1,3,0)
 ;;=3^Iris & Ciliary Body Vasular Disorders,Other,OD
 ;;^UTILITY(U,$J,358.3,13147,1,4,0)
 ;;=4^H21.1X1
 ;;^UTILITY(U,$J,358.3,13147,2)
 ;;=^5005175
 ;;^UTILITY(U,$J,358.3,13148,0)
 ;;=H18.462^^51^629^60
 ;;^UTILITY(U,$J,358.3,13148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13148,1,3,0)
 ;;=3^Peripheral Corneal Degeneration,OS
 ;;^UTILITY(U,$J,358.3,13148,1,4,0)
 ;;=4^H18.462
 ;;^UTILITY(U,$J,358.3,13148,2)
 ;;=^5005080
 ;;^UTILITY(U,$J,358.3,13149,0)
 ;;=H18.461^^51^629^59
 ;;^UTILITY(U,$J,358.3,13149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13149,1,3,0)
 ;;=3^Peripheral Corneal Degeneration,OD
 ;;^UTILITY(U,$J,358.3,13149,1,4,0)
 ;;=4^H18.461
 ;;^UTILITY(U,$J,358.3,13149,2)
 ;;=^5005079
 ;;^UTILITY(U,$J,358.3,13150,0)
 ;;=H21.82^^51^629^61
 ;;^UTILITY(U,$J,358.3,13150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13150,1,3,0)
 ;;=3^Plateau Iris Syndrome
 ;;^UTILITY(U,$J,358.3,13150,1,4,0)
 ;;=4^H21.82
 ;;^UTILITY(U,$J,358.3,13150,2)
 ;;=^5005264
 ;;^UTILITY(U,$J,358.3,13151,0)
 ;;=H21.542^^51^629^63
 ;;^UTILITY(U,$J,358.3,13151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13151,1,3,0)
 ;;=3^Posterior Synechiae,OS
 ;;^UTILITY(U,$J,358.3,13151,1,4,0)
 ;;=4^H21.542
 ;;^UTILITY(U,$J,358.3,13151,2)
 ;;=^5005252
 ;;^UTILITY(U,$J,358.3,13152,0)
 ;;=H21.541^^51^629^62
 ;;^UTILITY(U,$J,358.3,13152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13152,1,3,0)
 ;;=3^Posterior Synechiae,OD
 ;;^UTILITY(U,$J,358.3,13152,1,4,0)
 ;;=4^H21.541
 ;;^UTILITY(U,$J,358.3,13152,2)
 ;;=^5005251
